Brief: HLS Therapeutics receives conditional approval to graduate to the Toronto Stock Exchange
29/01/2019 11:44
Jan 29 (Reuters) - HLS Therapeutics Inc HLS.V :
* HLS THERAPEUTICS RECEIVES CONDITIONAL APPROVAL TO GRADUATE
TO
THE TORONTO STOCK EXCHANGE
* HLS THERAPEUTICS INC - UPON COMPLETION OF FINAL LISTING
REQUIREMENTS, HLS'S COMMON SHARES WILL BEGIN TRADING ON TSX
UNDER TICKER "HLS"
Source text for Eikon: ID:nCNWhzygRa
Further company coverage: HLS.V
((Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group